via University of Cambridge and Imperial College London
AI successfully used to identify different types of brain injuries
This tool will allow us to answer research questions we couldn’t answer before
The researchers, from the University of Cambridge and Imperial College London, have clinically validated and tested the AI on large sets of CT scans and found that it was successfully able to detect, segment, quantify and differentiate different types of brain lesions.
Their results, reported in The Lancet Digital Health, could be useful in large-scale research studies, for developing more personalised treatments for head injuries and, with further validation, could be useful in certain clinical scenarios, such as those where radiological expertise is at a premium.
Head injury is a huge public health burden around the world and affects up to 60 million people each year. It is the leading cause of mortality in young adults. When a patient has had a head injury, they are usually sent for a CT scan to check for blood in or around the brain, and to help determine whether surgery is required.
“CT is an incredibly important diagnostic tool, but it’s rarely used quantitatively,” said co-senior author Professor David Menon, from Cambridge’s Department of Medicine. “Often, much of the rich information available in a CT scan is missed, and as researchers, we know that the type, volume and location of a lesion on the brain are important to patient outcomes.”
Different types of blood in or around the brain can lead to different patient outcomes, and radiologists will often make estimates in order to determine the best course of treatment.
“Detailed assessment of a CT scan with annotations can take hours, especially in patients with more severe injuries,” said co-first author Dr Virginia Newcombe, also from Cambridge’s Department of Medicine. “We wanted to design and develop a tool that could automatically identify and quantify the different types of brain lesions so that we could use it in research and explore its possible use in a hospital setting.”
The researchers developed a machine learning tool based on an artificial neural network. They trained the tool on more than 600 different CT scans, showing brain lesions of different sizes and types. They then validated the tool on an existing large dataset of CT scans.
The AI was able to classify individual parts of each image and tell whether it was normal or not. This could be useful for future studies in how head injuries progress, since the AI may be more consistent than a human at detecting subtle changes over time.
“This tool will allow us to answer research questions we couldn’t answer before,” said Newcombe. “We want to use it on large datasets to understand how much imaging can tell us about the prognosis of patients.”
“We hope it will help us identify which lesions get larger and progress, and understand why they progress so that we can develop more personalised treatment for patients in future,” said Menon.
While the researchers are currently planning to use the AI for research only, they say with proper validation, it could also be used in certain clinical scenarios, such as in resource-limited areas where there are few radiologists.
In addition, the researchers say that it could have a potential use in emergency rooms, helping get patients home sooner. Of all the patients who have a head injury, only between 10 and 15% have a lesion that can be seen on a CT scan. The AI could help identify these patients who need further treatment, so those without a brain lesion can be sent home, although any clinical use of the tool would need to be thoroughly validated.
The ability to analyse large datasets automatically will also enable the researchers to solve important clinical research questions that have previously been difficult to answer, including the determination of relevant features for prognosis which in turn may help target therapies.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Star-shaped brain cells may play a critical role in glaucomaon June 23, 2020 at 8:02 am
After a brain injury, cells that normally nourish nerves may actually kill them instead, a new study in rodents finds. This "reactive" phenomenon may be the driving factor behind neurodegenerative ...
- University of Kentucky, Children’s Hospital of Philadelphia and Mitochon Pharmaceuticals Awarded NIH Grant for Traumatic Brain Injury Studieson June 23, 2020 at 7:00 am
Mitochon Pharmaceuticals, UKY and CHOP receive $3.2M NIH grant to study Mitochon's mitochondria targeted compounds for treating Traumatic Brain Injury ...
- 3 ways to improve your memory, according to a self-described brain coachon June 23, 2020 at 6:12 am
Forgetfulness can have a real cost in your daily life and your business, so it's worth it to strengthen your memory.
- Clear signs of brain injury with severe COVID-19on June 22, 2020 at 9:42 am
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a new study shows. In even moderate COVID-19 cases, finding ...
- MRI test to detect brain injuries in football playerson June 19, 2020 at 5:31 am
Chronic traumatic encephalopathy (CTE), a neurodegenerative disease caused by repeated head injuries often affecting athletes, can only be diagnosed currently through brain tissue analysis post ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Chicago setting up mobile COVID-19 testing sites to help monitor diseaseon June 23, 2020 at 12:02 pm
In an effort to get COVID-19 tests to people who need them, Mayor Lori Lightfoot on Tuesday announced mobile testing for residents in hard-hit African American neighborhoods on the South and West ...
- U.K. Cancer Charity Weighs $187 Million Cut to Disease Researchon June 23, 2020 at 6:03 am
Cancer Research UK may have to cut its research funding for potential treatments of the disease by 150 million pounds ($187 million) a year after the pandemic reduced its income.
- Timing The Market: How Warren Buffett And Disease Research Explain Its Ineffectivenesson June 23, 2020 at 5:33 am
Recent market turbulence has many wondering if now is the best time to buy stocks. To navigate this market, investors stand to learn a lot from both disease research and investment icons.
- Experts Warn Healthy People Against Taking Aspirin Daily To Prevent Heart Diseaseon June 23, 2020 at 4:20 am
Taking low-dose aspirin daily to prevent heart disease may not be very healthy after all, a recent review finds.
- Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki diseaseon June 23, 2020 at 2:19 am
This study was to investigate the correlation of vagal activity with coronary artery lesion (CAL) in Kawasaki disease (KD) children, and assess the predictive value of heart rate deceleration capacity ...